
AbbVie Inc.
ABBVNYSECIK 1551152HealthcareFiscal year ends Dec 31
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0817:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-24-058808 |
| 2024-05-0311:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001551152-24-000020 |
| 2024-04-2607:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000016 |
| 2024-04-0316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000013 |
| 2024-03-1816:15 ET | DEF 14A | Proxy statementPeriod 2024-05-03 | 0001558370-24-003496 |
| 2024-02-2617:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-027585 |
| 2024-02-2012:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001551152-24-000011 |
| 2024-02-2009:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-025262 |
| 2024-02-1207:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-013692 |
| 2024-02-0207:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000007 |
| 2024-01-0516:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-24-000002 |
| 2023-12-0617:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-124047 |
| 2023-11-3008:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-122241 |
| 2023-11-0613:01 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001551152-23-000045 |
| 2023-10-2707:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000040 |
| 2023-10-1217:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-108864 |
| 2023-10-0416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000036 |
| 2023-08-0713:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001551152-23-000033 |
| 2023-07-2707:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000028 |
| 2023-07-0616:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000026 |
| 2023-06-2917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-076373 |
| 2023-05-1017:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-058520 |
| 2023-05-0512:54 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001551152-23-000023 |
| 2023-04-2707:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000019 |
| 2023-04-0516:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000015 |
| 2023-03-2816:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-037749 |
| 2023-03-2017:00 ET | DEF 14A | Proxy statement | 0001558370-23-004204 |
| 2023-02-1712:54 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001551152-23-000011 |
| 2023-02-0907:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000006 |
| 2023-01-1008:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-002452 |
| 2023-01-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-23-000004 |
| 2022-11-2909:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-122661 |
| 2022-11-0413:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001551152-22-000045 |
| 2022-10-2807:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000038 |
| 2022-10-1709:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-109061 |
| 2022-10-1417:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-108910 |
| 2022-10-0516:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000034 |
| 2022-08-0415:57 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001551152-22-000030 |
| 2022-07-2907:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000026 |
| 2022-07-0616:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000023 |
| 2022-06-2908:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-075519 |
| 2022-06-2809:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-075039 |
| 2022-05-1117:06 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-058862 |
| 2022-05-0612:51 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001551152-22-000017 |
| 2022-04-2909:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000012 |
| 2022-04-2907:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001551152-22-000010 |
| 2022-04-2117:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-048450 |
| 2022-04-1309:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-045308 |
| 2022-03-2117:00 ET | DEF 14A | Proxy statementPeriod 2022-05-06 | 0001558370-22-004011 |
| 2022-03-0416:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-030613 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:34 ET. Listed shows no prices and gives no investment advice.